100 related articles for article (PubMed ID: 5822799)
21. A modified protein precipitation procedure for efficient removal of albumin from serum.
Chen YY; Lin SY; Yeh YY; Hsiao HH; Wu CY; Chen ST; Wang AH
Electrophoresis; 2005 Jun; 26(11):2117-27. PubMed ID: 15880626
[TBL] [Abstract][Full Text] [Related]
22. [Extraction of anti-tetanus polyglobulin from the plasma of actively immunized donors].
Minakova LV; Koz'minykh LF; Polishchuk MA
Zh Mikrobiol Epidemiol Immunobiol; 1967 Feb; 44(2):22-6. PubMed ID: 4177855
[No Abstract] [Full Text] [Related]
23. [Hemoperfusion and plasmapheresis complications].
Perino GC; Grivet V
Minerva Urol Nefrol; 1987; 39(2):161-3. PubMed ID: 3629414
[No Abstract] [Full Text] [Related]
24. [Blood products and plasma derivatives].
Faber JC
Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):45-53. PubMed ID: 3242960
[No Abstract] [Full Text] [Related]
25. [Development of the production of specific human immunoglobulins. III. Production of a test lot of specific anti-tetanus immunoglobulin].
Coria Jiménez R; Pérez de la Mora C; González Pacheco M; Villalva Posada H
Rev Latinoam Microbiol; 1984; 26(1):1-7. PubMed ID: 6484352
[No Abstract] [Full Text] [Related]
26. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
[TBL] [Abstract][Full Text] [Related]
27. Advances in plasmatic fractions used in blood transfusion.
Hollan SR
Rev Fr Transfus Immunohematol; 1979 Feb; 22(1):17-33. PubMed ID: 386471
[TBL] [Abstract][Full Text] [Related]
28. [Use of sodium caprylate for the separation of plasma proteins].
Allary M; Saint-Blancard J
Ann Pharm Fr; 1973; 31(7):513-20. PubMed ID: 4793461
[No Abstract] [Full Text] [Related]
29. [A new plasma exchange technique : coagulation studies (author's transl)].
Mathez D; Roussi J; Houbouyan L; Gajdos P; Tulliez M
Nouv Rev Fr Hematol (1978); 1981; 23(5):285-9. PubMed ID: 7329805
[TBL] [Abstract][Full Text] [Related]
30. Selective plasmapheresis using special secondary on line filters in therapy of immune disorders.
Siami G; Stone WJ
Prog Clin Biol Res; 1990; 337():355-7. PubMed ID: 2352994
[No Abstract] [Full Text] [Related]
31. [Therapeutic use of hemoderivatives].
Yurrebaso Eguilior N; Mota Villaplana FM; Montoro Ronsano JB
Sangre (Barc); 1997 Oct; 42(5):423-7. PubMed ID: 9424747
[No Abstract] [Full Text] [Related]
32. The effects of automated plasmapheresis on clinical, haematological, biochemical and coagulation variables in horses.
Feige K; Ehrat FB; Kästner SB; Wampfler B
Vet J; 2005 Jan; 169(1):102-7. PubMed ID: 15683770
[TBL] [Abstract][Full Text] [Related]
33. Use of digoxigenin-labelled probes for the detection of B19 parvovirus DNA in batches of blood products.
Lefrère JJ; Mariotti M
Cell Mol Biol (Noisy-le-grand); 1995 Nov; 41(7):985-8. PubMed ID: 8595378
[TBL] [Abstract][Full Text] [Related]
34. [Establishment and evaluation of the method for removing albumin and IgG in serum proteomics].
Li XH; Li X; Xu SJ; Ding YQ
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1233-5. PubMed ID: 15567765
[TBL] [Abstract][Full Text] [Related]
35. Donor plasmapheresis and regional self sufficiency.
Urbaniak SJ
Int J Artif Organs; 1984 Jan; 7(1):43-6. PubMed ID: 6421755
[No Abstract] [Full Text] [Related]
36. [New ion exchangers Trisacryl: use and application to plasma protein fractionation process (author's transl)].
Saint-Blancard J; Fourcart J; Limonne F; Girot P; Boschetti E
Ann Pharm Fr; 1981; 39(5):403-9. PubMed ID: 7325540
[No Abstract] [Full Text] [Related]
37. [Effect of long-term plasmapheresis on blood composition. II. Changes in the concentration of coagulation factors, inhibitors, thrombocytes and its effect on routine tests of coagulation].
Grgicević D
Bilt Hematol Transfuz; 1981; 9(1-3):89-100. PubMed ID: 7349762
[TBL] [Abstract][Full Text] [Related]
38. [Development of the production of specific human immunoglobulins. I. Titration of tetanus antitoxin in the process of obtaining normal human immunoglobulins].
Pérez de la Mora C; Mayorga Reyes L; González-Pacheco M; Ruiz Puente J
Rev Latinoam Microbiol; 1983; 25(3):145-54. PubMed ID: 6672933
[No Abstract] [Full Text] [Related]
39. [Production of blood coagulation factors and related factors by gene technology].
Suzuki K
Nihon Rinsho; 1987 Dec; 45(12):2971-82. PubMed ID: 2833649
[No Abstract] [Full Text] [Related]
40. Epimerization of moxalactam by albumin and simulation of in vivo epimerization by a physiologically based pharmacokinetic model.
Yoshikawa T; Oguma T; Ichihashi T; Kinoshita H; Hirano K; Yamada H
Chirality; 1999; 11(4):309-15. PubMed ID: 10224658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
